Erlosiban
N/A
Report date: 2025/11/11 20:00:28
NME
Base Information
Drug NameErlosiban
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[14]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMerck Serono
China Registration ClassN/A
Develop Information
Active CompaniesHangzhou Yuyuan Bioscience Technology Co LtdHangzhou Yuyuan Life Technology Co LtdReproNovo SA +[4]
Inactive CompaniesN/A
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A